Good afternoon, I’m still reporting on the coup.
Yes, unfortunately we now have to classify the COVID-19 pandemic as having become an integral part of the Desperado’s coup planning.
Maybe it didn’t start out that way, but you know the Democrat mantra …
Good afternoon, I’m still reporting on the coup.
Yes, unfortunately we now have to classify the COVID-19 pandemic as having become an integral part of the Desperado’s coup planning.
Maybe it didn’t start out that way, but you know the Democrat mantra – “never let a serious crisis go to waste.”
Well, call it a war, or just a skirmish, India is definitely siding with team Trump and the American people.
According to TimesNowNews.com, the Indian government has lifted its partial export ban on hydroxychloroquine, or HCQs, and has decided to allow the export of the highly in-demand drug to 13 countries, including, the USA, Germany, Spain, Bahrain, Brazil, and several others.
Around 14 million tablets will be distributed between all those nations, and enough of what’s called API – that is, active pharmaceutical ingredients - to make another 11 million tablets. This despite fears in India that the virus could still overwhelm India’s medical system and exhaust their own supply of the precious HCQs.
But India is taking extreme measures to obtain the raw materials from China by flying aircraft to China specifically to obtain the necessary ingredients because the pandemic has brought the normal method of transporting hundreds of tons of raw materials to a halt.
India just announced that it will become the first nation to distribute HCQs to prevent the spread of the COVID-19 virus in the largest slum area in Asia, in the slums of Mumbai, and other high-infection areas.
Despite India being the second most-populated nation with over 1.3 billion people – or nearly 18% of the world’s population – they rank way down at #18 in the numbers confirmed to have the COVID-19 virus. This is likely because India is the world’s largest manufacturer of HCQs.
According to recent United Nation’s estimates, the population of India will surpass that of China’s by 2027. India is the most populous democratic republic in the world
In another HCQ supply-side news, as reported here first, Britain’s NHS – the National Health Service – despite the coming widespread drug shortages that will likely occur in the U.S. - thanks to planning for a no-deal Brexit, the UK should be able to have supplies of all essential medicines available throughout so that their citizens suffer no shortages.
But they are now starting to protect current supplies by banning the export of some 80 medicines from the UK starting on March 20th – including insulin, para-cet-amol, and morphine used to treat patients in intensive care units.
An additional 52 medicines, including several respiratory medicines, antibiotics, analgesics and insulin products, were banned from export an April 1st.
That does not include HCQs at this time as long as it is sold to individuals living in other countries for personal use.
But the price will skyrocket before enough production can come online to satisfy world demand.
For example, this story just broke yesterday in India. Small scale pharmas will have to stop manufacturing HCQs because the prices of the raw materials have gone up by 800% in the last few weeks.
To be specific, according to pharma industry sources, the raw materials per kilogram were $120, but now they are $1,000 per kilo, and every country is now begging India for supplies of HCQs.. According to the same sources, even the Israeli pharma, Teva, who donated some 10 million doses to the U.S. on April 1st, is now making its HCQ in India and under the same constraints for the raw materials.
This is because there is precious little supply of the raw materials in the world with China’s chemical factories shuttered for several months, and that which does exist is being transported out of China by THE most expensive mode of travel – aircraft.
So the already limited supply will be met with an exponential increase in the demand, and the supply of newly manufactured product will not satisfy the world’s needs.
“No pharmacy in India will be able to carry this medicine any more. The price in India was 65 rupees per 10 tablets. That’s about 85 cents. Now the price has skyrocketed to 500 rupees per 10 – or about $6.53 per tablet.
“But in India, HCQs cannot legally be sold at that price because the government fixes the maximum selling price. This will also be the problem in the EU and Canada because of socialized medicine.
“So the expectation among industry experts is that there will be another 10-fold increase in the cost of this medicine in every free market country. Only the US will be exempted if the price is subsidized by the government.”
My source says that individuals can still buy enough HCQ for their personal needs, including zinc supplements at insulinhub.com. I’m not sure what the applicable U.S. laws are governing shipping it to the U.S. You will have to ask them. However, you should not take this drug without the approval your doctor before you purchase because HCQs has a very long half-life. It can build up in your blood to dangerous levels. My underst
